Wolverine Trading
LABU icon

Wolverine Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Wolverine Trading’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,300
Closed -$1.54M – 5205
2025
Q1 		$1.54M Sell
22,300
-41,700
-65% -$3.55M ﹤0.01% 1846
2024
Q4 		$5.73M Buy
64,000
+29,300
+84% +$3.45M 0.01% 1104
2024
Q3 		$4.4M Sell
34,700
-5,600
-14% -$731K ﹤0.01% 1132
2024
Q2 		$4.57M Sell
40,300
-1,800
-4% -$193K ﹤0.01% 1039
2024
Q1 		$5.59M Sell
42,100
-98,300
-70% -$12.8M 0.01% 951
2023
Q4 		$17.1M Buy
140,400
+129,135
+1,146% +$9.88M 0.02% 508
2023
Q3 		$858K Sell
11,265
-7,800
-41% -$800K ﹤0.01% 2239
2023
Q2 		$2.21M Buy
19,065
+2,435
+15% +$303K ﹤0.01% 1424
2023
Q1 		$1.55M Sell
16,630
-15
-0.1% -$2.03K ﹤0.01% 1552
2022
Q4 		$2.35M Buy
16,645
+25
+0.2% +$3.49K ﹤0.01% 1292
2022
Q3 		$2.29M Buy
16,620
+2,420
+17% +$444K ﹤0.01% 1319
2022
Q2 		$1.96M Sell
14,200
-3,775
-21% -$643K ﹤0.01% 1395
2022
Q1 		$5.76M Buy
17,975
+6,920
+63% +$2.61M 0.01% 990
2021
Q4 		$8.25M Buy
11,055
+3,155
+40% +$3.02M 0.01% 836
2021
Q3 		$8.7M Sell
7,900
-55
-0.7% -$67.6K 0.01% 902
2021
Q2 		$11.8M Buy
7,955
+3,190
+67% +$4.42M 0.02% 638
2021
Q1 		$6.67M Buy
+4,765
New +$11.2M 0.01% 931
2020
Q4 		– Sell
-3,010
Closed -$3.25M – 5167
2020
Q3 		$3.25M Buy
+3,010
New +$3.45M 0.01% 1127
2020
Q2 		– Sell
-4,105
Closed -$1.9M – 4925
2020
Q1 		$1.9M Buy
+4,105
New +$3.73M 0.01% 1391
2019
Q1 		– Sell
-6,575
Closed -$4.01M – 4927
2018
Q4 		$4.01M Sell
6,575
-120
-2% -$126K 0.01% 949
2018
Q3 		$12.5M Buy
+6,695
New +$13.2M 0.03% 462

Other funds holding LABU

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's LABU Position: Q2 2025 in Review

Wolverine Trading sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 6,242 shares — an estimated $431K sold.

Wolverine Trading first reported a position in LABU in Q3 2018 and held it in 18 quarters. The position peaked at $3.56M in Q4 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

  • Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 6,242 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $431K.
  • Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2018 and held it in 18 quarters.
  • Wolverine Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.56M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.